Related Experiment Videos

Drug resistance in Salmonellae isolated at Chandigarh (India) during 1972-1978

Antonie Van Leeuwenhoek
|January 1, 1980
PubMed

Insights

A study of 1316 Salmonella strains revealed significant drug resistance, with 38.3% exhibiting resistance and 23.5% showing multiple drug resistance. Gentamicin, furazolidone, and nalidixic acid remained effective against all tested Salmonella serotypes.

Area of Science:

  • Microbiology
  • Infectious Diseases
  • Antimicrobial Resistance

Background:

  • Salmonella infections pose a significant public health challenge globally.
  • Antimicrobial resistance in bacterial pathogens is a growing concern, complicating treatment strategies.
  • Understanding drug resistance patterns in Salmonella is crucial for effective disease management and public health interventions.

Purpose of the Study:

  • To investigate the prevalence and patterns of drug resistance in Salmonella serotypes isolated in India.
  • To identify specific Salmonella serotypes exhibiting multiple drug resistance.
  • To assess trends in Salmonella drug resistance over a defined period.

Main Methods:

  • Antimicrobial susceptibility testing was performed on 1316 Salmonella strains from 20 serotypes.
  • Disk diffusion or agar dilution methods were used to determine resistance to various antibiotics.
  • Data analysis focused on calculating resistance percentages and identifying patterns of multiple drug resistance.

Main Results:

  • 38.3% of Salmonella strains displayed drug resistance, with 23.5% showing resistance to multiple drugs.
  • High resistance rates were observed for ampicillin (32.5%), tetracycline (22.3%), and sulphadiazine (19.9%).
  • Salmonella serotypes S. bareilly, S. typhimurium, and S. anatum were most frequently associated with multiple drug resistance. All strains remained sensitive to gentamicin, furazolidone, and nalidixic acid.

Conclusions:

  • A notable increase in Salmonella drug resistance, including multidrug resistance, was observed between 1972 and 1978.
  • The emergence of multidrug-resistant Salmonella strains necessitates continuous monitoring and updated treatment guidelines.
  • Gentamicin, furazolidone, and nalidixic acid represent potential therapeutic options due to sustained sensitivity in the studied Salmonella population.

Related Concept Videos